Avadel Pharmaceuticals Plc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 0.00B-0.01B-0.01B0.00B0.00B0.00B0.04B-0.04B0.07B-0.10B-0.08B-0.01B-0.09B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation 0.01B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.00B0.00B0.01B0.01B0.02B0.02B
Deferred Taxes -0.00B0.00B0.01B0.00B-0.00B0.00B-0.00B0.02B0.01B0.01B0.02B-0.03B
Gains from Investment Securities 0.00B0.00B0.00B0.00B-0.00B0.01B0.01B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.03B
Asset Writedowns and Impairment 0.05B0.03B0.04B0.01B0.07B
Non-cash Items 0.04B0.03B0.03B0.03B
Cash from Operations 0.01B-0.01B-0.01B-0.02B-0.02B-0.01B0.08B0.02B0.02B-0.08B-0.04B-0.05B-0.08B-0.07B-0.13B-0.05B
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.00B0.01B0.01B0.00B0.01B0.00B
Depreciation & Amortization (CF) 0.01B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables 0.00B-0.00B0.00B-0.00B0.00B-0.00B0.01B0.01B-0.00B-0.00B-0.00B-0.01B0.01B0.02B
Change in Inventory -0.00B-0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B0.01B0.01B
Change in Account Payables 0.00B-0.00B-0.00B-0.00B0.00B0.01B-0.01B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B
Change in Accured Expenses -0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.01B0.01B-0.01B0.00B-0.01B0.00B0.00B0.02B0.02B
Change in Taxes -0.01B-0.01B-0.01B-0.00B-0.01B0.00B-0.00B0.00B-0.00B-0.00B-0.00B
Other Working Capital Changes 0.01B-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B-0.03B0.00B-0.00B
Investing Activities
Capital Expenditures 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Sales of Property, Plant and Equipment 0.00B0.00B0.00B0.00B0.01B0.00B
Change in Intangibles 0.05B0.02B
Acquisitions 0.00B0.00B
Divestments 0.03B0.02B
Change in Acquisitions & Divestments 0.14B0.08B0.03B0.02B0.01B0.02B0.05B0.07B0.19B0.36B0.06B0.04B0.10B0.08B0.19B0.33B
Cash from Investing Activities -0.02B0.01B-0.00B0.02B0.01B-0.04B-0.03B-0.04B-0.02B-0.04B0.04B-0.07B0.06B0.08B-0.05B0.05B
Financing Activities
Other financing activities 0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B
Cash from Financing Activities -0.00B-0.00B0.01B0.01B0.02B0.10B-0.02B-0.01B-0.02B0.11B-0.00B0.18B0.00B0.01B0.14B0.02B
Debt Issuance and Repayment
Non-Current Debt 52.55B
Net Debt Issuances and Repayments 52.55B
Additional items
Exchange Rate Effect -0.00B-0.00B-0.00B0.00B0.00B-0.01B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B
Change in Cash -0.02B-0.00B-0.00B-0.00B0.00B0.03B0.03B-0.03B-0.02B-0.01B0.00B0.06B-0.02B0.02B-0.04B0.02B
Beginning Cash Balance 0.03B0.01B0.01B0.00B0.00B0.01B0.04B0.07B0.04B0.02B0.01B0.01B0.07B-0.02B0.04B-0.02B
Free Cash Flow 0.01B-0.01B-0.01B-0.02B-0.02B-0.01B0.08B0.02B0.02B-0.08B-0.04B-0.05B-0.08B-0.07B-0.13B-0.05B
Net Cash Flow -0.02B-0.00B-0.00B-0.00B0.00B0.04B0.03B-0.03B-0.02B-0.01B0.00B0.06B-0.02B0.02B-0.04B0.02B